Portal de Periódicos da CAPES

Prevalence and trends of metabolic syndrome in Korea: Korean National Health and Nutrition Survey 1998–2001

2006; Wiley; Volume: 9; Issue: 1 Linguagem: Inglês

10.1111/j.1463-1326.2005.00569.x

1463-1326

Hong‐Seok Park, Seon Mee Kim, J. S. Lee, Juneyoung Lee, Jee Hye Han, D.K. Yoon, Sei Hyun Baik, Dong Seop Choi, Kyung Mook Choi,

Nutrition, Health and Food Behavior

Background: Metabolic syndrome (MetS) is a major international health problem. Limited information is available about the prevalence of MetS in Asia, especially in Korea. Objective: To examine the prevalence and trends of MetS in a Korean population. In addition, we investigated the risk factors associated with MetS. Design and Participants: A total of 7445 participants aged ≥20 years from the Korean National Health and Nutrition Survey (KNHNS) 1998 and 5964 participants from the KNHNS 2001 were included in this analysis. The KNHNS is a cross‐sectional health survey of a nationally representative sample of the Korean population. The prevalence of MetS was determined using the National Cholesterol Education Program Adult Treatment Panel III criteria and the Asia‐Pacific criteria for obesity based on waist circumference (APC‐WC). Results: Using the ATP III criteria, the age‐adjusted prevalence of MetS among Korean adults was 15.7% (13.7% male, 17.8% female) in 1998 and 14.4% (13.0% male, 16.2% female) in 2001. Using the APC‐WC criteria, the prevalence was 21.6% (19.4% male, 23.9% female) in 1998 and 21.4% (20.1% male, 23.4% female) in 2001. Of the five MetS components, increasing trends were found between 1998 and 2001 in the prevalence of hypertriglyceridaemia, low high‐density lipoprotein cholesterol and central obesity for both men and women. Age, sex, body mass index and a family history of diabetes were associated with MetS. Conclusions: These results from a representative sample show that MetS is common in Korean adults. A systemic public health programme is required to prevent future increases in diabetes and cardiovascular complications.